tradingkey.logo

10X Genomics Inc

TXG

11.920USD

0.0000.00%
收盘 07/07, 16:00美东报价延迟15分钟
1.47B总市值
亏损市盈率 TTM

10X Genomics Inc

11.920

0.0000.00%
关于 10X Genomics Inc 公司
10x Genomics, Inc. 是一家生命科学技术公司。该公司的综合解决方案包括用于分析生物系统的仪器、耗材和软件。其 Chromium 平台包括 Chromium X 系列、Chromium Connect 和传统 Chromium Controller 仪器、微流控芯片和相关耗材,可实现单个生物成分的通量分析。其 Visium 平台使研究人员能够以高分辨率了解组织内生物分析物的空间位置。其用于原位分析的 Xenium 平台旨在让科学家不仅能够在组织环境中定位和分类细胞。其产品包括 Chromium 单细胞基因表达、Chromium 单细胞基因表达 Flex、Chromium 单细胞免疫分析、Chromium 单细胞转座酶可及染色质 (ATAC) 检测、Chromium 单细胞多组 ATAC + 基因表达、Visium 空间基因表达等。
公司简介
公司代码TXG
公司名称10X Genomics Inc
上市日期Sep 12, 2019
成立日期2012
CEOMr. Serge Wilson Saxonov, Ph.D.
员工数量1306
证券类型Ordinary Share
年结日Sep 12
公司地址6230 Stoneridge Mall Road
城市PLEASANTON
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94588
电话19254017300
网址https://www.10xgenomics.com/
公司代码TXG
上市日期Sep 12, 2019
成立日期2012
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.09%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
369.61K
+4.34%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+29.09%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
59.45K
+34.83%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
52.17K
-12.55%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
28.62K
+115.82%
Dr. Shehnaaz Suliman, M.D.
Dr. Shehnaaz Suliman, M.D.
Independent Director
Independent Director
28.62K
+115.82%
Mr. Adam S. Taich
Mr. Adam S. Taich
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Alan V. Mateo
Mr. Alan V. Mateo
Independent Director
Independent Director
--
--
Dr. Sarah A. Teichmann
Dr. Sarah A. Teichmann
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.09%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
369.61K
+4.34%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+29.09%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
59.45K
+34.83%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
52.17K
-12.55%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
28.62K
+115.82%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Consumables
115.36M
74.48%
Products and services revenue
17.06M
11.01%
Instruments
14.81M
9.57%
Services
7.65M
4.94%
地区USD
名称
营收
占比
United States
86.82M
56.05%
Europe, the Middle East and Africa
31.89M
20.59%
China
16.88M
10.90%
Asia Pacific
15.54M
10.03%
Americas
3.75M
2.42%
业务
地区
业务USD
名称
营收
占比
Consumables
115.36M
74.48%
Products and services revenue
17.06M
11.01%
Instruments
14.81M
9.57%
Services
7.65M
4.94%
股东统计
更新时间: 5月23日 周五
更新时间: 5月23日 周五
持股股东
股东类型
持股股东
持股股东
占比
ARK Investment Management LLC
11.56%
The Vanguard Group, Inc.
9.99%
Fidelity Management & Research Company LLC
7.72%
Millennium Management LLC
4.98%
BlackRock Institutional Trust Company, N.A.
4.87%
Other
60.88%
持股股东
持股股东
占比
ARK Investment Management LLC
11.56%
The Vanguard Group, Inc.
9.99%
Fidelity Management & Research Company LLC
7.72%
Millennium Management LLC
4.98%
BlackRock Institutional Trust Company, N.A.
4.87%
Other
60.88%
股东类型
持股股东
占比
Investment Advisor
45.04%
Investment Advisor/Hedge Fund
22.18%
Hedge Fund
19.03%
Bank and Trust
5.32%
Research Firm
5.16%
Venture Capital
3.69%
Individual Investor
1.92%
Pension Fund
0.68%
Family Office
0.30%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
656
115.46M
103.93%
-12.51M
2025Q1
687
115.67M
104.27%
-8.84M
2024Q4
689
107.08M
98.92%
-12.41M
2024Q3
682
106.90M
100.39%
-9.08M
2024Q2
691
105.36M
99.70%
-5.09M
2024Q1
762
106.36M
101.17%
-3.12M
2023Q4
817
100.80M
96.01%
-9.73M
2023Q3
835
96.86M
93.80%
-12.55M
2023Q2
857
94.98M
96.77%
-15.37M
2023Q1
864
95.62M
97.55%
-9.91M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
ARK Investment Management LLC
12.85M
11.56%
+901.66K
+7.55%
Mar 31, 2025
The Vanguard Group, Inc.
11.09M
9.99%
+184.54K
+1.69%
Mar 31, 2025
Fidelity Management & Research Company LLC
8.58M
7.72%
-2.75M
-24.30%
Mar 31, 2025
Millennium Management LLC
5.53M
4.98%
+156.13K
+2.90%
Apr 01, 2025
BlackRock Institutional Trust Company, N.A.
5.41M
4.87%
-108.37K
-1.96%
Mar 31, 2025
Sumitomo Mitsui Trust Bank, Limited
5.36M
4.83%
+5.36M
--
Mar 31, 2025
UBS Asset Management (Switzerland)
4.10M
3.69%
+2.13M
+108.14%
Mar 31, 2025
Two Sigma Investments, LP
3.17M
2.85%
+614.32K
+24.04%
Mar 31, 2025
UBS Asset Management (Americas) LLC
2.90M
2.61%
+2.85M
+4.95K%
Mar 31, 2025
BofA Global Research (US)
2.56M
2.3%
+2.03M
+386.97%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
ARK Genomic Revolution ETF
3.47%
ARK Innovation ETF
1.55%
WisdomTree BioRevolution Fund
1.48%
Global X Genomics & Biotechnology ETF
1.35%
Invesco NASDAQ Future Gen 200 ETF
0.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.36%
ProShares Ultra Nasdaq Biotechnology
0.15%
Invesco Nasdaq Biotechnology ETF
0.11%
iShares Biotechnology ETF
0.1%
Goldman Sachs Innovate Equity ETF
0.08%
查看更多
ARK Genomic Revolution ETF
占比3.47%
ARK Innovation ETF
占比1.55%
WisdomTree BioRevolution Fund
占比1.48%
Global X Genomics & Biotechnology ETF
占比1.35%
Invesco NASDAQ Future Gen 200 ETF
占比0.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比0.36%
ProShares Ultra Nasdaq Biotechnology
占比0.15%
Invesco Nasdaq Biotechnology ETF
占比0.11%
iShares Biotechnology ETF
占比0.1%
Goldman Sachs Innovate Equity ETF
占比0.08%
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI